REFERENSI
CHAPPLE, Christopher R., et al. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourology and urodynamics, 2014, 33.1: 17-30.
TYAGI, Pradeep; TYAGI, Vikas; CHANCELLOR, Michael. Mirabegron: a safety review. Expert opinion on drug safety, 2011, 10.2: 287-294.
DEEKS, Emma D. Mirabegron: a review in overactive bladder syndrome. Drugs, 2018, 78: 833-844.
BRAGG, Rebecca, et al. Mirabegron: a beta-3 agonist for overactive bladder. The Consultant Pharmacist®, 2014, 29.12: 823-837.
O’KANE, Miriam, et al. Mirabegron in the management of overactive bladder syndrome. International Journal of Women’s Health, 2022, 1337-1350.
